Login

Journal Image
Medicinal Chemistry
ISSN (Print): 1573-4064
ISSN (Online): 1875-6638
VOLUME: 10
ISSUE: 6
DOI: 10.2174/15734064113096660050      Price:  $58









Discovery of Novel Lead in the Group of N-substituted Piperazine Ether Derivatives with Potential Histamine H3 Receptor Activity

img
Author(s): Kamil J. Kuder, Marta Stachnik, Walter Schunack, Ewa Szymanska and Katarzyna Kiec-Kononowicz
Pages 588-599 (12)
Abstract:
The search for novel lead from the group of various substituted N-piperazine ether derivatives was performed. Acyl- and pyridylpiperazine ethyl/propyl ethers were obtained via three different synthetic pathways. Affinity to histamine H3 receptor was established, as well as, for selected compounds, selectivity towards histamine H4R. Docking studies to the histamine H3R homology model strengthened the position of (4-(3-(4-(3-chlorobenzoyl)piperazin-1- yl)propoxy)phenyl)(cyclopropyl)methanone (compound 26) as a novel lead for further studies on histamine H3 receptor antagonist/inverse agonist.
Graphical Abstract:
Keywords:
Acylpiperazine, histamine H3R affinity, histamine H4R affinity, molecular docking, non-imidazole histamine H3R ligands.
Affiliation:
Department of Technology and Biotechnology of Drugs, Jagiellonian University, Medical College, Krakow, 30-688, Poland.